# Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults

> **NCT03043365** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 37 (actual)

## Conditions studied

- Lipoprotein Metabolism
- PCSK9
- Proteomics

## Interventions

- **DRUG:** control fish oil
- **DRUG:** LCMUFA-rich saury oil

## Key facts

- **NCT ID:** NCT03043365
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2019-05-29
- **Final completion:** 2019-11-21
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043365, "Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03043365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*